Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 156.25 | 33.46 | 86.00 | 99.25 | 0.8665 | 0.8254 |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 93.00 | 99.25 | 0.9370 | 0.9188 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 131.00 | 99.25 | 1.3199 | 1.3871 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 3.00 | 99.25 | 0.0302 | -0.7851 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 5.00 | 99.25 | 0.0504 | -0.7023 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 83.00 | 99.25 | 0.8363 | 0.7846 | |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 156.25 | 33.46 | 90.00 | 99.25 | 0.9068 | 0.8791 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 156.25 | 33.46 | 57.00 | 99.25 | 0.5743 | 0.4044 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 156.25 | 33.46 | 64.00 | 99.25 | 0.6448 | 0.5120 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 156.25 | 33.46 | 105.00 | 99.25 | 1.0579 | 1.0731 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 156.25 | 33.46 | 95.00 | 99.25 | 0.9572 | 0.9450 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 156.25 | 33.46 | 78.00 | 99.25 | 0.7859 | 0.7153 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 156.25 | 33.46 | 61.00 | 99.25 | 0.6146 | 0.4665 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 156.25 | 33.46 | 61.00 | 99.25 | 0.6146 | 0.4665 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 156.25 | 33.46 | 88.00 | 99.25 | 0.8867 | 0.8524 |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 85.00 | 99.25 | 0.8564 | 0.8118 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 156.25 | 33.46 | 128.00 | 99.25 | 1.2897 | 1.3521 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 156.25 | 33.46 | 81.00 | 99.25 | 0.8161 | 0.7570 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 7 | 156.25 | 33.46 | 118.00 | 99.25 | 1.1889 | 1.2332 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 156.25 | 33.46 | 58.00 | 99.25 | 0.5844 | 0.4201 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 156.25 | 33.46 | 123.00 | 99.25 | 1.2393 | 1.2931 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 156.25 | 33.46 | 95.00 | 99.25 | 0.9572 | 0.9450 |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 156.25 | 33.46 | 54.00 | 99.25 | 0.5441 | 0.3568 |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 98.00 | 99.25 | 0.9874 | 0.9839 | |
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 156.25 | 33.46 | 94.00 | 99.25 | 0.9471 | 0.9319 |